CRM197 reverses paclitaxel resistance by inhibiting the NAC‐1/Gadd45 pathway in paclitaxel‐resistant ovarian cancer cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CRM197 reverses paclitaxel resistance by inhibiting the NAC‐1/Gadd45 pathway in paclitaxel‐resistant ovarian cancer cells

Published:2019-09-06 Issue:14 Volume:8 Page:6426-6436
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Tang Xiao‐han¹,Li Hui¹,Zheng Xiu‐shuang¹,Lu Mei‐song¹^ORCID,An Yuan¹,Zhang Xiao‐lei¹

Affiliation:

1. Department of Gynecology and Obstetrics The First Affiliated Hospital of Harbin Medical University Harbin China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.2512

Reference24 articles.

1. ABCB1 (MDR1) induction defines a common resistance mechanism in paclitaxel- and olaparib-resistant ovarian cancer cells

2. Targeting the heparin-binding epidermal growth factor-like growth factor in ovarian cancer therapy

3. Heparin-binding epidermal growth factor-like growth factor as a novel targeting molecule for cancer therapy

4. Pre‐clinical study of BK‐UM, a novel inhibitor of HB‐EGF, for ovarian cancer therapy;Nam SO;Anticancer Res,2014

5. Effects of CRM197, a specific inhibitor of HB-EGF, in oral cancer

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug resistance in human cancers — Mechanisms and implications;Life Sciences;2024-09

2. ANGPTL3 diminishes the resistance of ovarian cancer to paclitaxel by blocking the PI3K-AKT-mTOR signaling pathway;Heliyon;2024-06

3. SYNERGISTIC ANTI-TUMOUR EFFECT OF DOXORUBICIN-HYDROCHLORIDE WITH CRM197, AN INHIBITOR OF HB-EGF, IN SQUAMOUS-CELL CARCINOMA;Biotechnologia Acta;2024-04-30

4. The Multiple Functions of HB-EGF in Female Reproduction and Related Cancer: Molecular Mechanisms and Targeting Strategies;Reproductive Sciences;2024-02-29

5. Identification of Copper Homeostasis-Related Gene Signature for Predicting Prognosis in Patients with Epithelial Ovarian Cancer;Cancer Informatics;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3